Vinay K Aakalu

Dr. Vinay K Aakalu

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2022 in The Ocular Surface
Verified
Journal Article
Closed access
HRHarkaran S. Rana
Harkaran S. Rana
SASruti S. Akella
Sruti S. Akella
CCCarson E. Clabeaux
Carson E. Clabeaux
ZSZachary P. Skurski
Zachary P. Skurski
VAVinay K Aakalu
Vinay K Aakalu

Verified
Journal Article
Open access
PDF file
SLSang Min Lee
Sang Min Lee
KSKyung-No Son
Kyung-No Son
DSDhara Shah
Dhara Shah
MAMarwan Ali
Marwan Ali
ABArun Balasubramaniam
Arun Balasubramaniam
VAVinay K Aakalu
Vinay K Aakalu
Macrophages play a critical role in the inflammatory response to environmental triggers, such as lipopolysaccharide (LPS). Inflammatory signaling through macrophages and the innate immune system are increasingly recognized as important contributors to multiple acute and chronic disease processes. Nitric oxide (NO) is a free radical that plays an important role in immune and inflammatory responses as an important intercellular messenger. In addition, NO has an important role in inflammatory responses in mucosal environments such as the ocular surface. Histatin peptides are well-established antimicrobial and wound healing agents. These peptides are important in multiple biological systems, playing roles in responses to the environment and immunomodulation. Given the importance of macrophages in responses to environmental triggers and pathogens, we investigated the effect of histatin-1 (Hst1) on LPS-induced inflammatory responses and the underlying molecular mechanisms in RAW264.7 (RAW) macrophages. LPS-induced inflammatory signaling, NO production and cytokine production in macrophages were tested in response to treatment with Hst1. Hst1 application significantly reduced LPS-induced NO production, inflammatory cytokine production, and inflammatory signaling through the JNK and NF-kB pathways in RAW cells. These results demonstrate that Hst1 can inhibit LPS-induced inflammatory mediator production and MAPK signaling pathways in macrophages.

1 April 2021 in The Ocular Surface
Verified
Journal Article
Closed access
CLCatherine Y. Liu
Catherine Y. Liu
AAAndrea C. Arteaga
Andrea C. Arteaga
SFSammie E. Fung
Sammie E. Fung
MCM. Soledad Cortina
M. Soledad Cortina
ILIlya M. Leyngold
Ilya M. Leyngold
VAVinay K Aakalu
Vinay K Aakalu

23 May 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DSDhara Shah
Dhara Shah
MAMarwan Ali
Marwan Ali
Deepak ShuklaDeepak Shukla
Deepak Shukla
SJSandeep Jain
Sandeep Jain
VAVinay K Aakalu
Vinay K Aakalu
Ocular surface and corneal epithelial wounds are common and potentially debilitating problems. Ideal treatments for these injuries would promote epithelial healing without inflammation, infection and scarring. In addition the best treatments would be cost-efficient, effective, non-toxic and easily applied. Histatin-1 peptides have been shown to be safe and effective enhancers of epithelial wound healing in other model systems. We sought to determine whether histatin-1 peptides could enhance human corneal epithelial wound healing in vitro. Histatin-1 peptides were applied to human corneal epithelial cells and compared over useful dose ranges in scratch assays using time-lapse microscopy. In addition, path finding analysis, cell spreading assays, toxicity and proliferation assays were performed to further characterize the effects of histatin-1 peptide on human corneal limbal epithelial (HCLE). Histatin-1 enhanced human corneal epithelial wound healing in typical wound healing models. There was minimal toxicity and no significant enhancement of proliferation of corneal epithelium in response to histatin-1 application. Corneal epithelial spreading and pathfinding appeared to be enhanced by the application of histatin-1 peptides. Histatin -1 peptide may enhance migration of HCLE cells and wound healing in vitro. These peptides may have benefit in corneal epithelial wounds and need to be investigated further.

29 January 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DSDhara Shah
Dhara Shah
MAMarwan Ali
Marwan Ali
ZPZeeshan Pasha
Zeeshan Pasha
AJAssraa Jassim Jaboori
Assraa Jassim Jaboori
SJSarmad H. Jassim
Sarmad H. Jassim
VAVinay K Aakalu
Vinay K Aakalu
Study of human lacrimal cell biology is limited by poor access to tissue samples, heterogeneous cell composition of tissue and a lack of established lacrimal epithelial markers. In order to further our understanding of lacrimal cell biology, we sought to find a better marker for human lacrimal epithelial cells, compared to what has been reported in the literature. We utilized human Muller’s muscle conjunctival resection (MMCR) specimens containing accessory lacrimal gland (ALG) and cadaveric main lacrimal gland (MLG) as sources of lacrimal tissue. Candidate markers were sought using human ALG tissue from MMCR specimens, isolated by laser capture microdissection (LCM). Affymetrix® analysis was performed on total RNA isolated from FFPE samples to profile transcription in ALG. MMCR tissue sections were assessed by immunofluorescence using antibodies for histatin-1, lactoferrin, E-cadherin (E-cad) and alpha-smooth muscle actin (ASMA). Reverse transcriptase polymerase chain reaction (RT-PCR) analysis was performed to analyze the expression of histatin-1, E-cad and lactoferrin from cadaveric MLG. Histatin-1 is expressed in ALG and MLG, localizes to lacrimal epithelium, and to a greater degree than do other putative lacrimal epithelial markers. Histatin-1 is a good marker for human lacrimal epithelium in ALG and MLG and can be used to identify lacrimal cells in future studies.

16 July 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SKSushma Kalmodia
Sushma Kalmodia
KSKyung-No Son
Kyung-No Son
DCDingcai Cao
Dingcai Cao
BLBao-Shiang Lee
Bao-Shiang Lee
BSBayasgalan Surenkhuu
Bayasgalan Surenkhuu
VAVinay K Aakalu
Vinay K Aakalu
The aims of this study were to determine if histatin-1 (H1) is present in normal human tears and whether tear levels of H1 varied between normal patients and those with aqueous deficient dry eye disease (ADDE). Patient samples were obtained from 11 normal patients and 11 severe ADDE patients. Relevant patient characteristics, including age, sex, and dry eye disease (DED) diagnostic parameters were collected. Multiple qualitative and quantitative methods were used to compare the concentration of H1 between patient groups. Mixed linear modeling was used to compare H1 levels between groups, and diagnostic performance was assessed using the receiver-operator-characteristic (ROC). ADDE patients had significantly lower H1 concentrations (85.9 ± 63.7 ng/ml) than the normal group (891.6 ± 196.5 ng/ml) (p < 0.001), while controlling for age and sex. ROC analysis indicated that H1 concentration is potentially a biomarker for ADDE (area under curve = 0.96). Reclassification of patients by DED parameters including, Ocular Surface Disease Index (OSDI) (≤13, >13) and Schirmer I (without anesthesia) (<10 mm, ≥10 mm) showed significant differences in H1 level (OSDI, p = 0.004) and Schirmer I ((p = 0.010). In conclusion, this is the first preliminary report of the presence of H1 in human tears. H1 concentrations are lower in ADDE patients and H1 may have diagnostic potential in evaluation ADDE patients.